 | • レポートコード：QAF27591 • 出版社/出版日：QYResearch / 2021年4月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のバイオシミラー薬市場について種類別（注射、錠剤、その他）、用途別（強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・バイオシミラー薬市場の概要 ・世界の主要地域別バイオシミラー薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオシミラー薬市場規模2016-2021：種類別（注射、錠剤、その他） ・世界のバイオシミラー薬市場予測2012-2027：種類別（注射、錠剤、その他） ・世界のバイオシミラー薬市場規模2016-2021：用途別（強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他） ・世界のバイオシミラー薬市場予測2012-2027：用途別（強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他） ・バイオシミラー薬のアメリカ市場規模と予測2016-2021 ・バイオシミラー薬のヨーロッパ市場規模と予測2016-2021 ・バイオシミラー薬の中国市場規模と予測2016-2021 ・バイオシミラー薬の日本市場規模と予測2016-2021 ・バイオシミラー薬の東南アジア市場規模と予測2016-2021 ・バイオシミラー薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Amgen、Eli Lilly、Novartis、CP Guojian Pharma、Biotech Pharma） ・バイオシミラー薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオシミラー薬の市場動向・機会・課題 ・調査の結論 |
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.
First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.
Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.
Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.
Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.
At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.
Market Analysis and Insights: Global Biosimilar Drug Market
The global Biosimilar Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Biosimilar Drug Scope and Market Size
The global Biosimilar Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Injection
Tablets
Other Types
Segment by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
The Biosimilar Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Biosimilar Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
1 Biosimilar Drug Market Overview
1.1 Biosimilar Drug Product Scope
1.2 Biosimilar Drug Segment by Type
1.2.1 Global Biosimilar Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Biosimilar Drug Segment by Application
1.3.1 Global Biosimilar Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Biosimilar Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biosimilar Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biosimilar Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biosimilar Drug Price Trends (2016-2027)
2 Biosimilar Drug Estimates and Forecasts by Region
2.1 Global Biosimilar Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biosimilar Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biosimilar Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Biosimilar Drug Revenue Market Share by Region (2016-2021)
2.3 Global Biosimilar Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biosimilar Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biosimilar Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biosimilar Drug Estimates and Projections (2016-2027)
2.4.2 Europe Biosimilar Drug Estimates and Projections (2016-2027)
2.4.3 China Biosimilar Drug Estimates and Projections (2016-2027)
2.4.4 Japan Biosimilar Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biosimilar Drug Estimates and Projections (2016-2027)
2.4.6 India Biosimilar Drug Estimates and Projections (2016-2027)
3 Global Biosimilar Drug Competition Landscape by Players
3.1 Global Top Biosimilar Drug Players by Sales (2016-2021)
3.2 Global Top Biosimilar Drug Players by Revenue (2016-2021)
3.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2020)
3.4 Global Biosimilar Drug Average Price by Company (2016-2021)
3.5 Manufacturers Biosimilar Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biosimilar Drug Market Size by Type
4.1 Global Biosimilar Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Biosimilar Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Biosimilar Drug Price by Type (2016-2021)
4.2 Global Biosimilar Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biosimilar Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilar Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Biosimilar Drug Price Forecast by Type (2022-2027)
5 Global Biosimilar Drug Market Size by Application
5.1 Global Biosimilar Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Biosimilar Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Biosimilar Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Biosimilar Drug Price by Application (2016-2021)
5.2 Global Biosimilar Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biosimilar Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilar Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilar Drug Price Forecast by Application (2022-2027)
6 North America Biosimilar Drug Market Facts & Figures
6.1 North America Biosimilar Drug Sales by Company
6.1.1 North America Biosimilar Drug Sales by Company (2016-2021)
6.1.2 North America Biosimilar Drug Revenue by Company (2016-2021)
6.2 North America Biosimilar Drug Sales Breakdown by Type
6.2.1 North America Biosimilar Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Biosimilar Drug Sales Breakdown by Type (2022-2027)
6.3 North America Biosimilar Drug Sales Breakdown by Application
6.3.1 North America Biosimilar Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Biosimilar Drug Sales Breakdown by Application (2022-2027)
7 Europe Biosimilar Drug Market Facts & Figures
7.1 Europe Biosimilar Drug Sales by Company
7.1.1 Europe Biosimilar Drug Sales by Company (2016-2021)
7.1.2 Europe Biosimilar Drug Revenue by Company (2016-2021)
7.2 Europe Biosimilar Drug Sales Breakdown by Type
7.2.1 Europe Biosimilar Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biosimilar Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Biosimilar Drug Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Biosimilar Drug Market Facts & Figures
8.1 China Biosimilar Drug Sales by Company
8.1.1 China Biosimilar Drug Sales by Company (2016-2021)
8.1.2 China Biosimilar Drug Revenue by Company (2016-2021)
8.2 China Biosimilar Drug Sales Breakdown by Type
8.2.1 China Biosimilar Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Biosimilar Drug Sales Breakdown by Type (2022-2027)
8.3 China Biosimilar Drug Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Biosimilar Drug Market Facts & Figures
9.1 Japan Biosimilar Drug Sales by Company
9.1.1 Japan Biosimilar Drug Sales by Company (2016-2021)
9.1.2 Japan Biosimilar Drug Revenue by Company (2016-2021)
9.2 Japan Biosimilar Drug Sales Breakdown by Type
9.2.1 Japan Biosimilar Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biosimilar Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Biosimilar Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biosimilar Drug Market Facts & Figures
10.1 Southeast Asia Biosimilar Drug Sales by Company
10.1.1 Southeast Asia Biosimilar Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Biosimilar Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Biosimilar Drug Sales Breakdown by Type
10.2.1 Southeast Asia Biosimilar Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biosimilar Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biosimilar Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)
11 India Biosimilar Drug Market Facts & Figures
11.1 India Biosimilar Drug Sales by Company
11.1.1 India Biosimilar Drug Sales by Company (2016-2021)
11.1.2 India Biosimilar Drug Revenue by Company (2016-2021)
11.2 India Biosimilar Drug Sales Breakdown by Type
11.2.1 India Biosimilar Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Biosimilar Drug Sales Breakdown by Type (2022-2027)
11.3 India Biosimilar Drug Sales Breakdown by Application
11.3.1 India Biosimilar Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Biosimilar Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biosimilar Drug Business
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Biosimilar Drug Products Offered
12.1.5 Amgen Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Biosimilar Drug Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Biosimilar Drug Products Offered
12.3.5 Novartis Recent Development
12.4 CP Guojian Pharma
12.4.1 CP Guojian Pharma Corporation Information
12.4.2 CP Guojian Pharma Business Overview
12.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CP Guojian Pharma Biosimilar Drug Products Offered
12.4.5 CP Guojian Pharma Recent Development
12.5 Biotech Pharma
12.5.1 Biotech Pharma Corporation Information
12.5.2 Biotech Pharma Business Overview
12.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotech Pharma Biosimilar Drug Products Offered
12.5.5 Biotech Pharma Recent Development
…
13 Biosimilar Drug Manufacturing Cost Analysis
13.1 Biosimilar Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilar Drug
13.4 Biosimilar Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilar Drug Distributors List
14.3 Biosimilar Drug Customers
15 Market Dynamics
15.1 Biosimilar Drug Market Trends
15.2 Biosimilar Drug Drivers
15.3 Biosimilar Drug Market Challenges
15.4 Biosimilar Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Biosimilar Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Biosimilar Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Biosimilar Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Biosimilar Drug Sales (K Dose) by Region (2016-2021)
Table 5. Global Biosimilar Drug Sales Market Share by Region (2016-2021)
Table 6. Global Biosimilar Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Biosimilar Drug Revenue Share by Region (2016-2021)
Table 8. Global Biosimilar Drug Sales (K Dose) Forecast by Region (2022-2027)
Table 9. Global Biosimilar Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Biosimilar Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Biosimilar Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Biosimilar Drug Sales (K Dose) of Key Companies (2016-2021)
Table 13. Global Biosimilar Drug Sales Share by Company (2016-2021)
Table 14. Global Biosimilar Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Biosimilar Drug Revenue Share by Company (2016-2021)
Table 16. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2020)
Table 17. Global Biosimilar Drug Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Biosimilar Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Biosimilar Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Biosimilar Drug Sales (K Dose) by Type (2016-2021)
Table 22. Global Biosimilar Drug Sales Share by Type (2016-2021)
Table 23. Global Biosimilar Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Biosimilar Drug Price (USD/Dose) by Type (2016-2021)
Table 25. Global Biosimilar Drug Sales Share by Type (2022-2027)
Table 26. Global Biosimilar Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Biosimilar Drug Revenue Share by Type (2022-2027)
Table 28. Global Biosimilar Drug Price (USD/Dose) by Type (2022-2027)
Table 29. Global Biosimilar Drug Sales (K Dose) by Application (2016-2021)
Table 30. Global Biosimilar Drug Sales Share by Application (2016-2021)
Table 31. Global Biosimilar Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Biosimilar Drug Price (USD/Dose) by Application (2016-2021)
Table 33. Global Biosimilar Drug Sales (K Dose) by Application (2022-2027)
Table 34. Global Biosimilar Drug Sales Share by Application (2022-2027)
Table 35. Global Biosimilar Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Biosimilar Drug Revenue Share by Application (2022-2027)
Table 37. Global Biosimilar Drug Price (USD/Dose) by Application (2022-2027)
Table 38. North America Biosimilar Drug Sales (K Dose) by Company (2016-2021)
Table 39. North America Biosimilar Drug Sales Market Share by Company (2016-2021)
Table 40. North America Biosimilar Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Biosimilar Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 43. North America Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 44. North America Biosimilar Drug Sales by Type (2022-2027) & (K Dose)
Table 45. North America Biosimilar Drug Sales Market Share by Type (2022-2027)
Table 46. North America Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 47. North America Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 48. North America Biosimilar Drug Sales by Application (2022-2027) & (K Dose)
Table 49. North America Biosimilar Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Biosimilar Drug Sales (K Dose) by Company (2016-2021)
Table 51. Europe Biosimilar Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Biosimilar Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Biosimilar Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 55. Europe Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Biosimilar Drug Sales by Type (2022-2027) & (K Dose)
Table 57. Europe Biosimilar Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 59. Europe Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Biosimilar Drug Sales by Application (2022-2027) & (K Dose)
Table 61. Europe Biosimilar Drug Sales Market Share by Application (2022-2027)
Table 62. China Biosimilar Drug Sales (K Dose) by Company (2016-2021)
Table 63. China Biosimilar Drug Sales Market Share by Company (2016-2021)
Table 64. China Biosimilar Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Biosimilar Drug Revenue Market Share by Company (2016-2021)
Table 66. China Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 67. China Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 68. China Biosimilar Drug Sales by Type (2022-2027) & (K Dose)
Table 69. China Biosimilar Drug Sales Market Share by Type (2022-2027)
Table 70. China Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 71. China Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 72. China Biosimilar Drug Sales by Application (2022-2027) & (K Dose)
Table 73. China Biosimilar Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Biosimilar Drug Sales (K Dose) by Company (2016-2021)
Table 75. Japan Biosimilar Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Biosimilar Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Biosimilar Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 79. Japan Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Biosimilar Drug Sales by Type (2022-2027) & (K Dose)
Table 81. Japan Biosimilar Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 83. Japan Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Biosimilar Drug Sales by Application (2022-2027) & (K Dose)
Table 85. Japan Biosimilar Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Biosimilar Drug Sales (K Dose) by Company (2016-2021)
Table 87. Southeast Asia Biosimilar Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Biosimilar Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Biosimilar Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 91. Southeast Asia Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Biosimilar Drug Sales by Type (2022-2027) & (K Dose)
Table 93. Southeast Asia Biosimilar Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 95. Southeast Asia Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Biosimilar Drug Sales by Application (2022-2027) & (K Dose)
Table 97. Southeast Asia Biosimilar Drug Sales Market Share by Application (2022-2027)
Table 98. India Biosimilar Drug Sales (K Dose) by Company (2016-2021)
Table 99. India Biosimilar Drug Sales Market Share by Company (2016-2021)
Table 100. India Biosimilar Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Biosimilar Drug Revenue Market Share by Company (2016-2021)
Table 102. India Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 103. India Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 104. India Biosimilar Drug Sales by Type (2022-2027) & (K Dose)
Table 105. India Biosimilar Drug Sales Market Share by Type (2022-2027)
Table 106. India Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 107. India Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 108. India Biosimilar Drug Sales by Application (2022-2027) & (K Dose)
Table 109. India Biosimilar Drug Sales Market Share by Application (2022-2027)
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Amgen Biosimilar Drug Product
Table 114. Amgen Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Eli Lilly Biosimilar Drug Product
Table 119. Eli Lilly Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Novartis Biosimilar Drug Product
Table 124. Novartis Recent Development
Table 125. CP Guojian Pharma Corporation Information
Table 126. CP Guojian Pharma Description and Business Overview
Table 127. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. CP Guojian Pharma Biosimilar Drug Product
Table 129. CP Guojian Pharma Recent Development
Table 130. Biotech Pharma Corporation Information
Table 131. Biotech Pharma Description and Business Overview
Table 132. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Biotech Pharma Biosimilar Drug Product
Table 134. Biotech Pharma Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Biosimilar Drug Distributors List
Table 138. Biosimilar Drug Customers List
Table 139. Biosimilar Drug Market Trends
Table 140. Biosimilar Drug Market Drivers
Table 141. Biosimilar Drug Market Challenges
Table 142. Biosimilar Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Biosimilar Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Ankylosing Spondylitis Examples
Figure 7. Tumor Examples
Figure 8. Rheumatoid Arthrtis Examples
Figure 9. Cardiovascular Examples
Figure 10. Other Application Examples
Figure 11. Global Biosimilar Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biosimilar Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Biosimilar Drug Sales (K Dose) Growth Rate (2016-2027)
Figure 14. Global Biosimilar Drug Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 15. Global Biosimilar Drug Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Biosimilar Drug Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Biosimilar Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Biosimilar Drug Sales (K Dose) Growth Rate (2016-2027)
Figure 19. Europe Biosimilar Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Biosimilar Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Biosimilar Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Biosimilar Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Biosimilar Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Biosimilar Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Biosimilar Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Biosimilar Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Biosimilar Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Biosimilar Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Biosimilar Drug Players Market Share by Revenue in Biosimilar Drug: 2016 & 2020
Figure 30. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Biosimilar Drug Revenue Share by Type (2016-2021)
Figure 32. Global Biosimilar Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Biosimilar Drug Revenue Share by Application (2016-2021)
Figure 34. Global Biosimilar Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Biosimilar Drug Sales Market Share by Type in 2020
Figure 36. North America Biosimilar Drug Sales Market Share by Application in 2020
Figure 37. Europe Biosimilar Drug Sales Market Share by Type in 2020
Figure 38. Europe Biosimilar Drug Sales Market Share by Application in 2020
Figure 39. China Biosimilar Drug Sales Market Share by Type in 2020
Figure 40. China Biosimilar Drug Sales Market Share by Application in 2020
Figure 41. Japan Biosimilar Drug Sales Market Share by Type in 2020
Figure 42. Japan Biosimilar Drug Sales Market Share by Application in 2020
Figure 43. Southeast Asia Biosimilar Drug Sales Market Share by Type in 2020
Figure 44. Southeast Asia Biosimilar Drug Sales Market Share by Application in 2020
Figure 45. India Biosimilar Drug Sales Market Share by Type in 2020
Figure 46. India Biosimilar Drug Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Biosimilar Drug
Figure 49. Manufacturing Process Analysis of Biosimilar Drug
Figure 50. Biosimilar Drug Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
インターフェロンα-2aバイオシミラーのグローバル市場2021 Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplasti…- バイオシミラーモノクローナル抗体のグローバル市場2021 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…
- 神経バイオシミラー生物製剤のグローバル市場調査 2019年 The global Nerve Biosimilar Biological Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nerve Biosimilar Biological Products volume and value at global level, regional level and company leve…
- インターフェロンアルファ-2bバイオシミラーのグローバル市場調査 2019年 The global Interferon Alpha-2b Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Alpha-2b Biosimilar volume and value at global level, regional level and company level. From a gl…
- ヒレセプチンバイオシミラーのグローバル市場調査 2019年 The global Hereceptin Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hereceptin Biosimilar volume and value at global level, regional level and company level. From a global perspective, …